Skip to main content
. 2022 May 31;20(2):320–329. doi: 10.9758/cpn.2022.20.2.320

Table 3.

Characteristics of subjects with subgroup analysis

Variable MPH start within 1 years after ADHD diagnosis (n = 625) MPH start within 3 years after ADHD diagnosis (n = 789)
Sex, male 502 (80.3) 634 (80.4)
Exposure duration (yr) 2.31 (0.84, 4.94) 2.34 (0.82, 5.06)
Duration of MPH exposure before 1st MDD event (yr) 1.00 (0.27, 2.57) 0.91 (0.17, 2.46)
Duration of MPH exposure after MDD diagnosis (yr) 0.51 (0.04, 2.18) 0.60 (0.04, 2.29)
Age at MPH exposure (yr) 8.00 (7.00, 9.00) 8.00 (7.00, 9.00)
Age at ADHD diagnosis (yr) 8.00 (7.00, 9.00) 8.00 (7.00, 9.00)
Age at MDD diagnosis (yr) 12.00 (9.00, 14.00) 12.00 (9.00, 14.00)
No. of outpatient visit (n) 155.00 (110.00, 222.00) 168.00 (115.00, 229.00)
No. of psychiatric outpatient visit (n) 59.00 (29.00, 95.00) 62.00 (33.00, 101.00)
MPH prescription duration at each visit 25.39 (16.80, 33.43) 25.84 (16.89, 33.45)
Antidepressant use (d) 107.00 (42.00, 280.00) 112.00 (42.00, 317.00)

Values are presented as number (%) or median (interquartile range).

MPH, methylphenidate; MDD, major depressive disorder; ADHD, Attention Deficit Hyperactivity Disorder.